DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 5DR REDDYS LABS SA
02 1STRIDES PHARMA INTL
03 11GRANULES
04 7ABHAI LLC
05 4ABLE
06 5ACCORD HLTHCARE
07 10ACTAVIS ELIZABETH
08 8ACTAVIS LABS FL
09 1ACTAVIS LABS FL INC
10 10ALKEM LABS LTD
11 9ALVOGEN
12 2AMNEAL
13 4AMNEAL PHARMS
14 1AMNEAL PHARMS CO
15 2ANDA REPOSITORY
16 4ANDOR PHARMS
17 4ANI PHARMS
18 1APPCO
19 11ASCENT PHARMS INC
20 4AUROLIFE PHARMA LLC
21 6AYTU BIOPHARMA
22 4BARR LABS INC
23 3BIONPHARMA
24 3CEDIPROF INC
25 2CHARTWELL MOLECULAR
26 1GLAND
27 1HERITAGE PHARMA
28 2HIBROW HLTHCARE
29 1HISUN PHARM HANGZHOU
30 6IMPAX LABS INC
31 4IRONSHORE PHARMS
32 4JANSSEN PHARMS
33 9LANNETT CO INC
34 3MOUNTAIN
35 3MPP PHARMA
36 1NEXTWAVE
37 3NEXTWAVE PHARMS
38 1NOVARTIS
39 6NOVEL LABS INC
40 2NOVITIUM PHARMA
41 12OSMOTICA PHARM US
42 3OXFORD PHARMS
43 3PRINSTON INC
44 4PURDUE PHARMA LP
45 5QUAGEN
46 11RHODES PHARMS
47 1RISING
48 8SANDOZ
49 1SCIEGEN PHARMS
50 19SPECGX LLC
51 1STRIDES PHARMA
52 1SUN PHARM
53 6SUN PHARM INDS INC
54 4TEVA PHARMS
55 3TEVA PHARMS USA
56 2TEVA PHARMS USA INC
57 1TP ANDA HOLDINGS
58 2TRIS PHARMA INC
59 1UNICHEM
60 4WATSON LABS
01 63CAPSULE, EXTENDED RELEASE;ORAL
02 3CAPSULE;ORAL
03 2FOR SUSPENSION, EXTENDED RELEASE;ORAL
04 1FOR SUSPENSION;ORAL
05 1SOLUTION/DROPS;OPHTHALMIC
06 20SOLUTION;ORAL
07 13TABLET, CHEWABLE;ORAL
08 6TABLET, EXTENDED RELEASE, CHEWABLE;ORAL
09 87TABLET, EXTENDED RELEASE;ORAL
10 65TABLET;ORAL
01 81DISCN
02 174RX
03 6Blank
01 4ADHANSIA XR
02 2APREMILAST
03 7APTENSIO XR
04 1BIMATOPROST
05 1BUPROPION HYDROCHLORIDE
06 4CONCERTA
07 1DOXEPIN HYDROCHLORIDE
08 4JORNAY PM
09 6METADATE CD
10 2METADATE ER
11 5METHYLIN
12 2METHYLIN ER
13 192METHYLPHENIDATE HYDROCHLORIDE
14 1METHYLPREDNISOLONE
15 1OLANZAPINE
16 1OLMESARTAN MEDOXOMIL
17 1ORPHENADRINE CITRATE
18 1OSELTAMIVIR PHOSPHATE
19 1OXYBUTYNIN CHLORIDE
20 1PREGABALIN
21 3QUILLICHEW ER
22 1QUILLIVANT XR
23 1RANITIDINE HYDROCHLORIDE
24 7RELEXXII
25 3RITALIN
26 5RITALIN LA
27 1RITALIN-SR
28 2TRAZODONE HYDROCHLORIDE
01 205No
02 50Yes
03 6Blank
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code : AB1
Brand Name : METHYLPHENIDATE HYDROCHLORIDE
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 20MG
Approval Date : 2011-12-01
Application Number : 78458
RX/OTC/DISCN : RX
RLD : No
TE Code : AB1
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
RLD : No
TE Code :
Brand Name : METHYLPHENIDATE HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 54MG
Approval Date : 2019-07-15
Application Number : 204659
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
RLD : No
TE Code : AB
Brand Name : METHYLPHENIDATE HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 10MG
Approval Date : 2018-11-21
Application Number : 210992
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code : AB1
Brand Name : METHYLPHENIDATE HYDROCHLORIDE
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 30MG
Approval Date : 2011-12-01
Application Number : 78458
RX/OTC/DISCN : RX
RLD : No
TE Code : AB1
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code : AB1
Brand Name : METHYLPHENIDATE HYDROCHLORIDE
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 40MG
Approval Date : 2011-12-01
Application Number : 78458
RX/OTC/DISCN : RX
RLD : No
TE Code : AB1
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code : AB1
Brand Name : METHYLPHENIDATE HYDROCHLORIDE
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 60MG
Approval Date : 2016-06-23
Application Number : 78458
RX/OTC/DISCN : RX
RLD : No
TE Code : AB1
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code : AB1
Brand Name : METHYLPHENIDATE HYDROCHLORIDE
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 10MG
Approval Date : 2018-02-26
Application Number : 200886
RX/OTC/DISCN : RX
RLD : No
TE Code : AB1
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
RLD : No
TE Code : AB
Brand Name : METHYLPHENIDATE HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 20MG
Approval Date : 2018-11-21
Application Number : 210992
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
RLD : No
TE Code : AB1
Brand Name : METHYLPHENIDATE HYDROCHLORIDE
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 10MG
Approval Date : 2019-05-23
Application Number : 211796
RX/OTC/DISCN : RX
RLD : No
TE Code : AB1
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
RLD : No
TE Code : AB1
Brand Name : METHYLPHENIDATE HYDROCHLORIDE
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 20MG
Approval Date : 2019-05-23
Application Number : 211796
RX/OTC/DISCN : RX
RLD : No
TE Code : AB1
